Hillsdale Investment Management Inc.

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1368465 Toronto, A6

Position in ADPT

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$8,678,011

-$1,341,257 QoQ

Shares Held

625,217

+1.3% QoQ

Ownership

0.391%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 97.0766949715059.ToString("F0")% Shared 0.ToString("F0")% None 2.9233050284941067.ToString("F0")%

Healthcare · as of Mar 31, 2026

Hillsdale Investment Management Inc. holds $21,291,906 across 4 Diagnostics & Research names. ADPT ranks #2 (40.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GH	Guardant Health, Inc.	124,384	$11,489,350
2	ADPT	Adaptive Biotechnologies Corp This page	625,217	$8,678,011
3	IQV	Iqvia Holdings Inc.	4,980	$849,289
4	TMO	Thermo Fisher Scientific Inc.	560	$275,256

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,678,011	625,217	+1.3%	Shares	Sole	2026-05-04
2025-12-31	$10,019,268	616,950	-0.8%	Shares	Sole	2026-02-10
2025-09-30	$9,301,978	621,790	+9.5%	Shares	Sole	2025-11-10
2025-06-30	$6,618,248	568,090	—	Shares	Sole	2025-08-12
No filing history on record for this holder in this stock.